MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult Patients
Clinical trial NCT06237192 · RECRUITING
Trial details
- NCT number
- NCT06237192
- Sponsor
- National Research Center for Hematology, Russia
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2026-09-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.